Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2005
12/08/2005WO2005115433A2 Methods for cyclizing synthetic polymers
12/08/2005WO2005115394A2 Prenyl-electrostatic switch, and methods of use
12/08/2005WO2005115363A2 Method for treating skeletal disorders resulting from fgfr malfunction
12/08/2005WO2005115354A2 Compositions and methods for bone formation and remodeling
12/08/2005WO2005115136A2 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases
12/08/2005WO2005098422A3 Detecting recessive diseases in inbred populations
12/08/2005WO2005097828A3 Peptides of cav2.2 that inhibit pain
12/08/2005WO2005095973A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54)
12/08/2005WO2005094188A3 Method of invasiveness control and use of adiponectin
12/08/2005WO2005094187A3 Labeling substance and chimera substance, process for preparing these substances, and method of biosubstance trapping, structural analysis or/and identification with use of the labeling substance
12/08/2005WO2005091956A3 In vitro test system for predicting patient tolerability of therapeutic agents
12/08/2005WO2005090970B1 Device and method for detecting analytes by visualization and separation of agglutination
12/08/2005WO2005089944A3 Microfluidic chip
12/08/2005WO2005089442A3 Inhibitors of gob-4 protein as asthma therapeutics
12/08/2005WO2005085855A3 System and method for integrating fluids and reagents in self-contained cartridges containing sensor elements and reagent delivery systems
12/08/2005WO2005083125A3 Surrogate markers of neuropathic pain
12/08/2005WO2005082080A3 Method to modulate the immune system with a novel guanine nucleotide exchange factor
12/08/2005WO2005080992A3 P-glycoprotein assay
12/08/2005WO2005078454A3 Methods for determining the amount of peptide yy in blood
12/08/2005WO2005078126A3 Means for detecting and treating cancer cells resistant to therapeutic agents
12/08/2005WO2005076013A3 Process for screening glycoform-specific antibodies
12/08/2005WO2005075994A3 Biosensor and method for operating the latter
12/08/2005WO2005075448A3 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained
12/08/2005WO2005073729A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y11 (p2y11)
12/08/2005WO2005073338A3 Fluorescent, semi-conductive polymers, and devices comprising them
12/08/2005WO2005070447A3 M-csf muteins and uses thereof
12/08/2005WO2005069012A3 Ligands for i7l as modulators of orthopox viruses and methods for discovery thereof
12/08/2005WO2005060721A3 Manipulation of rna interference through modulation of armitage activity
12/08/2005WO2005055810A3 Risk markers for cardiovascular disease
12/08/2005WO2005053770A3 A self-condensing ph sensor
12/08/2005WO2005051662A3 Methods for detecting l-ficolin dependent activation of the lectin pathway of complement and kits therefor
12/08/2005WO2005050208A3 Method and device for improved cleaning of a substance bound to paramagnetic microparticles
12/08/2005WO2005045395A3 Method of detecting bovine spongiform encephalopathy
12/08/2005WO2005045058A3 Detecting human anti-therapeutic antibodies
12/08/2005WO2005040111A3 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acids
12/08/2005WO2005038734A3 Authentication of products using molecularly imprinted polymers
12/08/2005WO2005037859A3 Fluorescence assay for kinase activity
12/08/2005WO2005029068A9 Iconic colorimetric test device with reduced susceptibility to false positive and false negative readings
12/08/2005WO2005023987A3 Cell-based assays for determining drug action
12/08/2005WO2005021784A3 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching
12/08/2005WO2005012944A3 Geosteering detectors for boring-type continuous miners
12/08/2005WO2005001906A3 Materials and methods for near-infrared and infrared lymph node mapping
12/08/2005WO2005000875A3 Compositions and methods comprising a ligand of chemerin receptor
12/08/2005WO2004082617A3 Biological markers for diagnosing rheumatoid arthritis
12/08/2005WO2004066948A3 Mapcaxs as modifiers of the apc and axin pathways and methods of use
12/08/2005WO2004058042A3 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
12/08/2005WO2004056315A8 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/08/2005WO2004050704A8 Therapeutic and diagnostic agents
12/08/2005WO2003104263A3 Cytokines and cytokine receptors with reduced immunogenicity
12/08/2005WO2003060148A3 Androgen regulated nucleic acid molecules and encoded proteins
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050273871 Method for diagnosing arrhythmogenic right ventricular dysplasia
12/08/2005US20050273867 Non-invasive real-time in vivo bioluminescence imaging of local Ca²+ dynamics in living organisms
12/08/2005US20050273275 Method and system for profiling biological systems
12/08/2005US20050273274 Method for identifying sub-sequences of interest in a sequence
12/08/2005US20050273271 Method of characterizing cell shape
12/08/2005US20050273270 Profile searching in nucleic acid sequences using the fast fourier transformation
12/08/2005US20050273269 Method and system for analysis of biological and chemical data
12/08/2005US20050273268 Method and system for quantifying and removing spatial-intensity trends in microarray data
12/08/2005US20050273267 Method for identifying markers
12/08/2005US20050273032 Filter and biosensor having the same
12/08/2005US20050273016 Gas analyzer calibration checking device
12/08/2005US20050272989 Analyte sensors and methods for making and using them
12/08/2005US20050272916 Method of modulating the activity of functional immune molecules
12/08/2005US20050272915 Skrp, astray, string, vacm associated with metabolic control
12/08/2005US20050272824 Methods for monitoring combretastatin resistance
12/08/2005US20050272796 Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs
12/08/2005US20050272795 Prevention and treatment of benign prostatic hyperplasia
12/08/2005US20050272767 Method for treating myolytic disease and method for screening antimyolytic agent
12/08/2005US20050272684 Breast cancer resistance protein (BCRP) and the DNA which encodes it
12/08/2005US20050272681 Ribosome structure and protein synthesis inhibitors
12/08/2005US20050272648 Ghrelin analogs
12/08/2005US20050272640 Combined control of insulin bolus dosing and basal delivery for the goal of achieving normal glycemic response to meals, exercise, stressors, and other perturbations to blood glucose levels
12/08/2005US20050272636 Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-gamma
12/08/2005US20050272268 Method of producing substrate having patterned organosilane layer and method of using the substrate having the patterned organosilane layer
12/08/2005US20050272167 Methods and systems for detecting hydrogen
12/08/2005US20050272166 Methods and systems for detection, identification and quantitation of macrolides and their impurities
12/08/2005US20050272165 Method for detecting protein as fluorescence image
12/08/2005US20050272164 Identification of modified peptides by mass spectrometry
12/08/2005US20050272163 Separating from excipient active hematinic species present in iron-saccharidic compositions, such as sodium ferric gluconate complex, ferric hydroxide-sucrose complex and ferric saccharate complex; analytical quantification by liquid chromatography and lasers of molecular characterisations; drugs
12/08/2005US20050272162 Contacting a high-density lipoprotein with an oxidized phospholipid combined with a low density lipoprotein (LDL); and measuring a change in the amount of oxidized or non-oxidized phospholipid; evaluating the risk for atherosclerosis in a mammal
12/08/2005US20050272159 Device and method for pressure-driven plug transport and reaction
12/08/2005US20050272158 Method and apparatus for detecting hydrocarbons with NMR logs in wells drilled with oil-based muds
12/08/2005US20050272157 Method of evaluating freshness of a fish product
12/08/2005US20050272145 Hand-held fluorescence polarimeter
12/08/2005US20050272130 Methods and compositions relating to prion-only transmission of yeast strains
12/08/2005US20050272121 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination
12/08/2005US20050272118 biological conjugated drug binding with a detectable label, or toxin maytansine and calicheamicin; monoclonal antibody as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs
12/08/2005US20050272110 Biomarkers; multi-photon detection; colorimetry; breast, prostate cancer
12/08/2005US20050272109 Method for immobilizing conjugates in diagnostic tests
12/08/2005US20050272108 Stabilized two component system for chemiluminescent assay in immunodiagnostics
12/08/2005US20050272106 Methods and kits for detection of multiple pathogens
12/08/2005US20050272105 Bacterial biosensors
12/08/2005US20050272104 Method for detection of Mycobacterium tuberculosis antigens in biological fluids
12/08/2005US20050272103 Cell separation matrix
12/08/2005US20050272102 Method for diagnosis of prostate cancer
12/08/2005US20050272101 Method for the early detection of renal injury
12/08/2005US20050272100 Separation and quantification of biotinylated macromolecules
12/08/2005US20050272098 Quantitation of endothelial microparticles
12/08/2005US20050272097 Methods and compositions for detecting and treating autoimmune diseases